October 21, 2020
Business News

Novavax Partners With Takeda to Sell Its Coronavirus Vaccine in Japan – Motley Fool

Novavax(NASDAQ:NVAX) is teaming up with Japanese drug maker Takeda Pharmaceutical(NYSE:TAK) to sell Novavax’s coronavirus vaccine, NVX-CoV2373, as a prevention for COVID-19 in Japan.
Takeda will be responsible for manufacturing the protein part of the vaccine and will get some help from Japan’s Ministry of Health, Labour and Welfare. The agency has pledged to help fund the manufacturing technology transfer, establishment of infrastructure, and scale-up of manufacturing for the vaccine.

Click here to view the original article.

Related Posts

You might also like ...

Dream Industrial REIT October 2020 Monthly Distribution
AON Splash Image
Marin Healthcare District Appoints David G. Klein, MD, MBA as Chief Executive Officer
Quad to Host Investors and Analysts Call to Discuss Third Quarter 2020 Results